Evista aids bone health in lupus patients
Thu, 29 Dec 2005 07:20 PM EST
... NEW YORK (Reuters Health) - A small study has shown that the osteoporosis drug raloxifene, sold as Evista, helps maintain bone mineral density (BMD) in menopausal women with systemic lupus erythematosus (SLE) who are on corticosteroids. ...
Related Topics
- Raloxifene
- Lupus
- Bone Health
- Hearing Aids
- HIV/AIDS & STDs
- Bone Disease
- Vaccinations For HIV/AIDs Patients
- Bone Marrow
- Lupus Anticoagulant
- Acquired Immune Deficiency Syndrome
- Bone Diseases
- Systemic Lupus Erythematosus
- Bone Cancer
- Healthcare Workers
- Osteoporosis
- AIDS - Living and Coping
- Lupus Nephritis
- Pediatric Aids
- AIDS and Infections
- Mental Health

Not Signed In -


